Abstract | AIMS: METHODS: This study was carried out as a post-hoc landmark analysis of a randomized, controlled, multicenter, prospective intervention trial. We included 1173 elderly type 2 diabetes patients (aged ≥ 65 years) from 39 Japanese institutions who were enrolled in the Japanese elderly diabetes intervention trial study and who could be followed up for 1 year. A landmark survival analysis was carried out in which follow up was set to start 1 year after the initial time of entry. RESULTS: CONCLUSIONS:
|
Authors | Atsushi Araki, Satoshi Iimuro, Takashi Sakurai, Hiroyuki Umegaki, Katsuya Iijima, Hiroshi Nakano, Kenzo Oba, Koichi Yokono, Hirohito Sone, Nobuhiro Yamada, Junya Ako, Koichi Kozaki, Hisayuki Miura, Atsunori Kashiwagi, Ryuichi Kikkawa, Yukio Yoshimura, Tadasumi Nakano, Yasuo Ohashi, Hideki Ito, Japanese Elderly Intervention Trial Research Group |
Journal | Geriatrics & gerontology international
(Geriatr Gerontol Int)
Vol. 12 Suppl 1
Pg. 18-28
(Apr 2012)
ISSN: 1447-0594 [Electronic] Japan |
PMID | 22435937
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Copyright | © 2012 Japan Geriatrics Society. |
Chemical References |
- Biomarkers
- Cholesterol, HDL
- Cholesterol, LDL
- Lipoproteins
- lipoprotein cholesterol
- Cholesterol
|
Topics |
- Aged
- Aged, 80 and over
- Biomarkers
(blood)
- Cholesterol
(blood)
- Cholesterol, HDL
(blood)
- Cholesterol, LDL
(blood)
- Diabetes Complications
(blood, diagnosis)
- Diabetes Mellitus, Type 2
(blood, complications, mortality)
- Female
- Follow-Up Studies
- Humans
- Japan
(epidemiology)
- Lipoproteins
(blood)
- Male
- Risk Factors
- Stroke
(diagnosis, etiology)
|